首页> 外文会议>World Congress for Bronchology >Changing diagnostic strategies of mediastinal and hilar lymphadenopathies: EBUS-TBNA diagnosing benign lesions.
【24h】

Changing diagnostic strategies of mediastinal and hilar lymphadenopathies: EBUS-TBNA diagnosing benign lesions.

机译:改变纵隔和肺门淋巴结病的诊断策略:EBUS-TBNA诊断良性病变。

获取原文

摘要

Here we report the results of endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA) use in 181 patients with mediastinal lymphadeno-pathy. EBUS-TBNA was applied to 58 female and 123 male (mean age 64,2 years and 24,4- 91,5 yrs range). Cytological exams were performed to all formalin fixed paraffin-embedded cell block and smear preparations obtained by biopsying lymph nodes from 2l, 2r, 4r, 4l, 7, 10r, 10l and 11l regions. Benign lesions were verified in 48% of cases whereas sarcoidosis in 35, caseating granulomas in 4 and cystic lesion in one. 44 patient cytograms showed nonspecific reactive lymphadenopathy and majority, 52% of the cohort revealed different malignant mediastinal processes. No complications were observed. EBUS-TBNA as the strategic first choice technology could be applied as a minimally invasive diagnostic approach to either in benign or malignant mediastinal and hilar lymphadenopathies. High specificity and accuracy can be ensured in diagnosing different benign lesions incl. sarcoidosis with safe and cost-effective way.
机译:在这里,我们在181例纵隔淋巴结患者中报道了内核上的超声引导横向针吸附(EBUS-TBNA)的结果。 Abus-tbna应用于58名女性和123名男性(平均年龄64,2岁,24,4-91,5岁范围)。对所有福尔马林固定的石蜡嵌入细胞嵌段进行细胞学检查,并通过来自2L,2R,4R,4L,7,10R,10L和11L区域的活检淋巴结获得的涂片制剂。在48%的病例中核实了良性病变,而35中的结节病,在4个和囊性病变中的粒度肉芽肿。 44例患者细胞图显示出非特异性的活性淋巴结病,大多数,52%的队列显示出不同的恶性纵隔过程。没有观察到任何并发症。作为战略第一选择技术的EBUS-TBNA可以应用于良性或恶性纵隔和肺门淋巴结病的微创诊断方法。可以确保诊断不同的良性病变,可以确保高特异性和准确性。结节病,具有安全且经济高效的方式。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号